Pluri
Zellbasierte Produkte und Technologieplattformen für Plazentazellen.
Pluri stellt in seinem Betrieb in Haifa zellbasierte Produkte und Technologieplattformen für Plazentazellen her. Das Unternehmen beliefert Gesundheitssysteme, Labore, OEM-Partner oder regulierte Exportkunden in seinen aufgeführten Hauptmärkten.
- Type
- brand seeking distribution
- Location
- Haifa, Israel
- Founded
- 2001
- Website
- pluri-biotech.com
- Categories
- Medizin- & Gesundheitsbedarf
- Markets
- Israel, Vereinigte Staaten, Deutschland, Japan
Verified facts
- domain-registered (green), checked 2026-08-09 Domain registry record
- debarment-clear (green), checked 2026-08-09 OpenSanctions
- sanctions-clear (green), checked 2026-08-09 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-09 Mail server of the company domain
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)